- Home
- GP vs MRKR Comparison
GP vs MRKR Comparison
Compare GP & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- MRKR
- Stock Information
- Founded
- GP 2010
- MRKR N/A
- Country
- GP Canada
- MRKR United States
- Employees
- GP N/A
- MRKR N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- MRKR Health Care
- Exchange
- GP Nasdaq
- MRKR Nasdaq
- Market Cap
- GP 22.7M
- MRKR 21.9M
- IPO Year
- GP 2020
- MRKR N/A
- Fundamental
- Price
- GP $0.79
- MRKR $2.16
- Analyst Decision
- GP Strong Buy
- MRKR Strong Buy
- Analyst Count
- GP 2
- MRKR 1
- Target Price
- GP $2.33
- MRKR $19.00
- AVG Volume (30 Days)
- GP 224.7K
- MRKR 53.9K
- Earning Date
- GP 02-11-2025
- MRKR 11-14-2024
- Dividend Yield
- GP N/A
- MRKR N/A
- EPS Growth
- GP N/A
- MRKR N/A
- EPS
- GP N/A
- MRKR N/A
- Revenue
- GP $21,595,069.00
- MRKR $5,395,849.00
- Revenue This Year
- GP N/A
- MRKR $64.48
- Revenue Next Year
- GP $103.69
- MRKR N/A
- P/E Ratio
- GP N/A
- MRKR N/A
- Revenue Growth
- GP N/A
- MRKR 79.04
- 52 Week Low
- GP $0.70
- MRKR $1.83
- 52 Week High
- GP $2.93
- MRKR $5.99
- Technical
- Relative Strength Index (RSI)
- GP 46.03
- MRKR 32.84
- Support Level
- GP $0.80
- MRKR $1.83
- Resistance Level
- GP $0.84
- MRKR $2.79
- Average True Range (ATR)
- GP 0.09
- MRKR 0.28
- MACD
- GP 0.00
- MRKR -0.09
- Stochastic Oscillator
- GP 17.53
- MRKR 21.02
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.